helper t cells

Can Helper T Cells Be Targeted for Cancer Therapy?

Yes, targeting helper T cells is a promising approach in cancer therapy. Therapies include:
- Checkpoint Inhibitors: Drugs like pembrolizumab and nivolumab block checkpoint molecules (e.g., PD-1/PD-L1), thereby revitalizing exhausted helper T cells.
- Cytokine Therapy: Administering cytokines like IL-2 can boost the proliferation and activation of helper T cells.
- Cancer Vaccines: These vaccines aim to present tumor antigens to helper T cells in a way that triggers a robust anti-tumor response.

Frequently asked queries:

Partnered Content Networks

Relevant Topics